Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_410984a8f2b665c9ef58ba24f4960b1d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_716e9a2606ffd4ba1a2a3917e4a402fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67a5089c7bd9243893f671d168476676 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65e2d56f922b5ea965162a506c59ce82 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-03 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0642 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0787 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
filingDate |
2010-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_926cc5a09069bbb9d6a06775f9f98f6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b51a4d17a8b313524d99952c5847fff4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6b588f4e99e80c94860e3bc7f93b84e |
publicationDate |
2011-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2011030915-A1 |
titleOfInvention |
Method for producing mast cells from pluripotent stem cells |
abstract |
The present invention relates to a method for producing human mast cells from human pluripotent stem cells. More particularly, the present invention provides a method for producing human mast cells from human pluripotent stem cells, comprising the steps of: (a) culturing human pluripotent stem cells under a condition suitable for promoting differentiation of the human pluripotent stem cells into hematopoietic progenitor cells expressing CD34; and (b) culturing the cells obtained in step (a) in the presence of hematopoietic factors comprising thrombopoietin (TPO) and Flt3 ligand. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-6051378-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9617517-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018043714-A1 |
priorityDate |
2009-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |